GlassScriptPhysician profile
Gregory L Smith
NPI 1770977886
$54,555.41
in general payments reported to CMS, 2019-2025
12 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,535 · 2020: $651 · 2021: $1,816 · 2022: $961 · 2023: $3,264 · 2024: $6,842 · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $31K · Travel and Lodging: $14K · Food and Beverage: $4,782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,775.00 |
| Travel and Lodging | $14,034.84 |
| Food and Beverage | $4,782.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $23,487.00 | 2022-2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $19,220.06 | 2022-2025 | Evoke, Evoke Scs |
| Abbott Laboratories | $7,869.68 | 2019-2025 | Proclaim, Eterna |
| Stratus Medical, LLC | $1,771.37 | 2020-2024 | Nimbus |
| Mml US, INC. | $994.01 | 2022-2025 | Reactiv8 |
| Relievant Medsystems, INC. | $528.98 | 2021 | |
| Boston Scientific Corporation | $308.26 | 2024 | Intracept |
| Medtronic USA, INC. | $205.80 | 2020 | |
| Nevro Corp. | $99.83 | 2022 | |
| Averitas Pharma INC. | $29.43 | 2025 | Qutenza |
| Vertos Medical, INC. | $25.79 | 2021 | |
| Tersera Therapeutics LLC | $15.20 | 2025 | Prialt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.